Viemed Reaffirms 2026 Guidance and Authorizes New 5% Buyback
VMD sits 42% above its 52-week low of $6.05.
Summary
Viemed Healthcare filed an 8-K with an investor presentation reaffirming 2026 guidance and announcing a new 5% share repurchase authorization.
Key Events · Earnings and Guidance · VMD
-
2026 Guidance Reaffirmed
Full-year 2026 net revenue guidance of $314M–$320M and Adjusted EBITDA of $64M–$68M, consistent with prior outlook.
-
New 5% Buyback Authorized
Board authorized a new share repurchase program for up to 5% of shares outstanding, the fourth such program.
-
1H 2026 Buyback Activity
Repurchased 680,802 shares for $6.5M at an average price of $9.57 per share, above the current $8.57.
-
Strong Q2 2026 Metrics
Q2 revenue of $78.1M (up 24% YoY), Adjusted EBITDA of $13.7M, TTM free cash flow of $34M, and zero net debt.
Analysis · VMD · Industrial Applications And Services
The investor deck reaffirms full-year 2026 guidance of $314M–$320M revenue and $64M–$68M Adjusted EBITDA, while the board authorized a new share repurchase program for up to 5% of shares outstanding. In 1H 2026, the company repurchased 680,802 shares for $6.5M at an average price of $9.57, above today's $8.57. The buyback signals management confidence and provides a floor for the stock, though the authorization is not a commitment to purchase.
How filings like this one have moved
In the 30 days to Aug 22, 2026, 29.1% of the 2927 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VMD was trading at $8.57 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $326.4M. The 52-week trading range was $6.05 to $12.61. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.